Envoy Medical (COCH) Cash from Operations (2021 - 2026)
Envoy Medical's Cash from Operations history spans 5 years, with the latest figure at 6061000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 62.71% to 6061000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 20537000.0, a 27.68% decrease, with the full-year FY2025 number at 18201000.0, down 1.4% from a year prior.
- Cash from Operations hit 6061000.0 in Q1 2026 for Envoy Medical, down from 5685000.0 in the prior quarter.
- Over the last five years, Cash from Operations for COCH hit a ceiling of 1099000.0 in Q3 2023 and a floor of 11145000.0 in Q4 2023.
- Historically, Cash from Operations has averaged 4006294.12 across 5 years, with a median of 4331000.0 in 2025.
- The widest YoY moves for Cash from Operations: up 120.92% in 2023, down 908.1% in 2023.
- Tracing COCH's Cash from Operations over 5 years: stood at 2379000.0 in 2022, then crashed by 368.47% to 11145000.0 in 2023, then soared by 54.32% to 5091000.0 in 2024, then dropped by 11.67% to 5685000.0 in 2025, then dropped by 6.61% to 6061000.0 in 2026.
- Business Quant data shows Cash from Operations for COCH at 6061000.0 in Q1 2026, 5685000.0 in Q4 2025, and 4331000.0 in Q3 2025.